中文名 | 去亚甲基小檗碱 |
---|---|
英文名 | 9,10-dimethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium-2,3-diol |
英文别名 |
demethyleneberberine
2,3-Dihydroxy-9,10-dimethoxy-7,8,13,14-tetradehydro-berbinium 2,3-dihydroxy-9,10-dimethoxy-5,6-dihydroisoquino[3,2-a]isoquinolinium 7,8,13,13a-tetradehydro-9,10-dimethoxy-2,3-dihydroxy-berbinium 2,3-dihydroxy-9,10-dimethoxy-5,6-dihydro-isoquino[3,2-a]isoquinolinylium Demethylen-berberin Dibenzo[a,g]quinolizinium,5,6-dihydro-2,3-dihydroxy-9,10-dimethoxy |
描述 | Demethyleneberberine 是一种天然线粒体靶向抗氧化剂。Demethyleneberberine 通过抑制 NF-κB 通路和调节 Th 细胞的平衡来减轻小鼠结肠炎并抑制炎症反应。Demethyleneberberine 可作为 AMPK 激活剂,用于治疗非酒精性脂肪性肝病 (NAFLD)。 |
---|---|
相关类别 | |
参考文献 |
分子式 | C19H18NO4+ |
---|---|
分子量 | 323.34300 |
精确质量 | 323.11600 |
PSA | 59.64000 |
LogP | 1.64990 |
储存条件 | 室温 |
~43% 25459-91-0 |
文献:XINTRIA PHARMACEUTICAL CORPORATION, INC.; LIPPA, Arnold, Stan Patent: WO2010/104595 A1, 2010 ; Location in patent: Page/Page column 103 ; |
~% 25459-91-0 |
文献:Bioorganic and Medicinal Chemistry Letters, , vol. 16, # 5 p. 1380 - 1383 |
~% 25459-91-0 |
文献:Bioorganic and Medicinal Chemistry Letters, , vol. 16, # 5 p. 1380 - 1383 |